Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 1
2014 1
2015 1
2016 1
2018 1
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy.
van der Meer PB, Habets EJJ, Wiggenraad RG, Verbeek-de Kanter A, Lycklama À Nijeholt GJ, Zwinkels H, Klein M, Dirven L, Taphoorn MJB. van der Meer PB, et al. Among authors: verbeek de kanter a. J Neurooncol. 2018 Sep;139(2):359-368. doi: 10.1007/s11060-018-2868-7. Epub 2018 Apr 16. J Neurooncol. 2018. PMID: 29663172 Free PMC article.
Neurocognitive functioning and health-related quality of life in patients treated with stereotactic radiotherapy for brain metastases: a prospective study.
Habets EJ, Dirven L, Wiggenraad RG, Verbeek-de Kanter A, Lycklama À Nijeholt GJ, Zwinkels H, Klein M, Taphoorn MJ. Habets EJ, et al. Among authors: verbeek de kanter a. Neuro Oncol. 2016 Mar;18(3):435-44. doi: 10.1093/neuonc/nov186. Epub 2015 Sep 18. Neuro Oncol. 2016. PMID: 26385615 Free PMC article.
Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT, Link EK, Whelan TJ, Olivotto IA, Kunkler I, Westenberg AH, Gruber G, Schofield P, Chua BH; BIG 3-07/TROG 07.01 trial investigators. King MT, et al. Lancet Oncol. 2020 May;21(5):685-698. doi: 10.1016/S1470-2045(20)30085-1. Epub 2020 Mar 20. Lancet Oncol. 2020. PMID: 32203696 Clinical Trial.
Local progression and pseudo progression after single fraction or fractionated stereotactic radiotherapy for large brain metastases. A single centre study.
Wiggenraad R, Verbeek-de Kanter A, Mast M, Molenaar R, Kal HB, Lycklama à Nijeholt G, Vecht C, Struikmans H. Wiggenraad R, et al. Among authors: verbeek de kanter a. Strahlenther Onkol. 2012 Aug;188(8):696-701. doi: 10.1007/s00066-012-0122-3. Epub 2012 Jun 23. Strahlenther Onkol. 2012. PMID: 22722818